Angiotensin II modulation of insulin-like growth factor I expression in the cardiovascular system

被引:9
作者
Delafontaine, P
Brink, M
Du, J
机构
[1] Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, 1639 Pierce Dr.
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1050-1738(96)00058-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The renin-angiotensin system is important in the pathophysiology of hypertension, cardiac hypertrophy, heart failure, and vascular remodeling. Angiotensin II is a growth factor for vascular smooth muscle cells and for cardiac myocytes and non-myocytes. Recently, angiotensin II has been shown to interact at multiple levels with the insulin-like growth factor I (IGF-I) system. IGF-I is a major regulator of developmental growth, and of cellular metabolism and differentiation acting by endocrine and autocrine/paracrine pathways. Angiotensin II activates IGF-I receptor signaling through multiple mechanisms, and this activation is required for the growth-promoting effects of angiotensin II on vascular smooth muscle. Angiotensin II also stimulates cardiac IGF-I gene expression. Contrary to its effects on vascular and cardiac IGF-I expression, angiotensin II depresses circulating IGF-I through a presser-independent anorexigenic effect. The anorexigenic effect of angiotensive II, and an additional metabolic effect, produce marked weight loss in the angiotensin II-infused animal. The alterations in local and circulating IGF-I expression produced by angiotensive II ave potentially of importance in understanding the pathophysiology of conditions in which the renin-angiotensin system is activated.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 65 条